Loading...

Pak Fah Yeow International Limited

0239.HKHKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$2.49
HK$0.03(1.22%)

Pak Fah Yeow International Limited (0239.HK) Stock Overview

Explore Pak Fah Yeow International Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.5/100

Key Financials

Market Cap776M
P/E Ratio9.75
EPS (TTM)$0.25
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Week$2.42
1 Month$2.36
3 Months$2.54
1 Year Target$3.38

0239.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pak Fah Yeow International Limited (0239.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.75 and a market capitalization of 776M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;